On the other hand, APOE status can be used as a balancing factor when selecting samples across multiple sites since selection of SCD samples with equal rates of APOE4 will increase cross-sample homogeneity with regard to the presence of preclinical AD. Here, APOE is linked to Schnyder corneal dystrophy.